CDK8-Novel Therapeutic Opportunities

Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzl, Ingeborg, Witalisz-Siepracka, Agnieszka, Sexl, Veronika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630639/
https://www.ncbi.nlm.nih.gov/pubmed/31248103
http://dx.doi.org/10.3390/ph12020092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630639/
https://www.ncbi.nlm.nih.gov/pubmed/31248103
http://dx.doi.org/10.3390/ph12020092

Ejemplares similares